The management of severe psychiatric disorder: A comparison of the use of neuroleptic medication in two intensive therapy units

Prescribing for personality disorder: qualitative study of interviews with general and forensic consultant psychiatrists

“…37 The findings also suggest that the lack of continuity of the doctor-patient relationship obscures diagnosis, leads to difficulty in modifying established prescriptions and may predispose to crises resulting in overprescribing. Evidence of high rates of polypharmacy in this group is gathering strength and the phenomenon of overtreatment in medicine in general is increasingly recognised 38,39 and the many reasons for this need more exploration.…”

“…The study underlines that ‘non-patient factors’ 36 can be strong determinants of prescription patterns, including: access to psychological treatments and specialist services, prescriber view of medication effectiveness and the type of institution in which the patient is encountered. 37 The findings also suggest that the lack of continuity of the doctor-patient relationship obscures diagnosis, leads to difficulty in modifying established prescriptions and may predispose to crises resulting in overprescribing. Evidence of high rates of polypharmacy in this group is gathering strength and the phenomenon of overtreatment in medicine in general is increasingly recognised 38 , 39 and the many reasons for this need more exploration.…”

Practice Based Evidence (PBE) and therapies: personal recommendations from the 30 years of the CORE system (Evidencia basada en la práctica (EBP) y psicoterapias: recomendaciones personales basadas en los 30 años del sistema CORE)

“…I am not against psychotropic medication in principle and have researched the complexities of using it (Baker-Glenn et al, 2010; Hillam & Evans, 1996; Hillam et al, 1997; Konstantinidou & Evans, 2015; Martean & Evans, 2014). Where psychotropic medication can be given ‘double blind’ so that neither the prescriber nor the client knows what the client is prescribed, then I am sure that RCTs give us useful generalities about the value of the medication.…”

“…En principio, no estoy en contra de la medicación psicotrópica, y he investigado las complicaciones que supone utilizarlas (Baker-Glenn et al, 2010; Hillam & Evans, 1996; Hillam et al, 1997; Konstantinidou & Evans, 2015; Martean & Evans, 2014). Cuando la medicación psicotrópica puede administrarse ‘doble ciego’, una situación donde ni el profesional que la prescribe ni el cliente conocen qué es lo que se receta, estoy seguro de que los ECRs nos ofrecen generalidades útiles sobre el valor de la medicación.…”